|
We collected the 2004 -2005 annual incidence of 3 months (acute phase) and the incidence of three months to a year and a half (recovery) Community Stroke Patients were Chaoyang District, Changchun City Hospital, Changchun First Automobile Factory General Hospital, Jilin cerebrovascular disease hospital under the jurisdiction of the residents of the community, were randomly selected as the treatment group and the control group. A total of 200 patients, divided into the acute phase of illness and convalescent cases, the treatment group: 100 patients in the control group: 100 cases. Every 100 cases, 50 cases of the acute phase cases: 35 cases of cerebral infarction, cerebral hemorrhage in 15 cases; recovery period 50 patients: 35 cases of cerebral infarction, cerebral hemorrhage 15 cases. Selected two groups of patients are helped by community physicians and site guidance, all cases of group home monitoring of blood pressure, heart rate, blood glucose, blood lipids, blood viscosity. Payment of stroke rehabilitation manual will publicize the prevention and treatment of stroke knowledge, develop good habits, given psychological guidance. The treatment group developed according to the specific circumstances of different patients appropriate rehabilitation measures, ADL training, OT therapy, PT therapy. The control group was not intervene. Application of clinical degree of neurological deficits Scale, Modified Barthel Index (Barthel Index) rating scale, functional comprehensive assessment (Functional compreshesive assessment FCA) analysis and evaluation at the time of enrollment (V1), two after the end of the month selected (V2 ), selected fifth after the end of the month (V3) were evaluated three times. Application SPSS12.0 statistical processing software for processing data x ± s, t-test, X2 test or rank sum test. The results showed that: 1, cerebral infarction, cerebral hemorrhage in patients with treatment group and control group comparison. V1 patients with cerebral infarction treatment group and the control group was no difference (P gt; 0.05), brain hemorrhage hand function control group is better than the treatment group (P lt; 0.05), the remaining evaluation no difference (P gt; 0.05). V2 cerebral infarction FCA score V1 differences (P lt; 0.05), cerebral hemorrhage, shoulder and arm movement, walking ability score V1 differences (P lt; 0.05), the remaining difference (P gt; 0.05). V3 the cerebral infarction FCA rated group and between groups (P lt; 0.05), cerebral hemorrhage shoulder and arm movement, walking ability, Barthel, FCA ratings V1 differences (P lt; 0.05), the rest no difference (P gt; 0.05 ). 2, the acute phase, the treatment group and the control group of patients recovering from the comparison. V1 acute phase of the control group patients, shoulder and arm movement, hand movement than the treatment group function better (P lt; 0.05), Barthel score of convalescent patients the treatment group compared with the control group (P lt; 0.05). No difference V2 acute phase treatment group and the control group (P gt; 0.05), comparison group walk, FCA scores improved (P lt; 0.05), lower limb motor scores increased significantly (P lt; 0.01); V2 convalescent Barthel treatment group and control group differences (P LT; 0.05). V3 acute phase treatment group and a control group of patients no differences (P gt; 0.05), shoulder and arm movement, FCA group comparison significance (P lt; 0.05), lower limb motor scores improved significantly (P lt; 0.01); V3 convalescent FCA treatment group and the control group within the group and between groups were different (P LT; 0.05), the the the Barthel treatment group and control group, differences (P LT; 0.01). 3, the treatment group and the control group in patients with acute and convalescent comparison. V1 treatment group rated acute and convalescent significant difference (P lt; 0.01), convalescent ratings. Acute and convalescent stage of the control group, no differences (P gt; 0.05). V2 acute phase of the treatment group, shoulder and arm movement, hand movement, lower limb function recovered rapidly, significant difference (P lt; 0.01), Barthel score difference (P lt; 0.05), FCA groups within the group. Acute and convalescent walking ability of the control group difference (P lt; 0.05). The the V3 treatment group comparison of acute and convalescent, shoulder and arm movements, lower limb function, walking ability, Barthel, FCA group within the score showed a significant difference (P lt; 0.01), hand movement differences (P lt; 0.05). The control group walking ability, FCA rated the acute phase than the recovery period (P lt; 0.05), the rest of the evaluation was no difference (P gt; 0.05).
|